(305) Ratiometric coloaded human serum albumin nanoparticles for effective breast cancer treatment
Introduction: Breast cancer is one of the leading causes of mortality worldwide. As per the report by the American Cancer Society, for the year 2024-2025, an estimated 310 720 new invasive breast cancer and 56,500 cases of ductal carcinoma in situ will be diagnosed among women in the US, and an additional 2,790 cases will be diagnosed in men [1]. The present chemotherapeutics may suffer from resistance to therapy, relapse and adverse interactions. There is a dire need for novel and advanced chemotherapeutic options which can solve the problems mentioned above.
Learning Objectives:
To understand the targeted ratio metric codelivery delivery of two chemotherapeutics agents.
To comprehend the reduction in individual doses with the combinatorial drug delivery
To embrace the efficacy of two drugs with diverse physicochemical properties in cancer treatment.
